U.S. Pharmaceutical Cro Market Size & Outlook, 2026-2033

Name: U.S. Pharmaceutical Cro Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The pharmaceutical cro market in the United States is expected to reach a projected revenue of US$ 21,786.2 million by 2033. A compound annual growth rate of 8% is expected of the United States pharmaceutical cro market from 2026 to 2033.

HC Outsourcing
- CRO
  - Pharmaceutical CRO Market Outlook

U.S. pharmaceutical cro type outlook (Revenue, USD million, 2021-2033)
- Drug Discovery
  - Target Validation
  - Lead Identification
  - Lead Optimization
- Pre-Clinical
- Clinical
  - Phase I Trial Services
  - Phase II Trial Services
  - Phase III Trial Services
  - Phase IV Trial Services
U.S. pharmaceutical cro molecule type outlook (Revenue, USD million, 2021-2033)
- Small Molecules
- Large Molecules
U.S. pharmaceutical cro services outlook (Revenue, USD million, 2021-2033)
- Project Management/Clinical Supply Management
- Data Management
- Regulatory/Medical Affairs
- Medical Writing
- Clinical Monitoring
- Quality Management/ Assurance
- Bio-statistics
- Investigator Payments
- Laboratory
- Patient And Site Recruitment
- Technology
- Others
U.S. pharmaceutical cro therapeutic areas outlook (Revenue, USD million, 2021-2033)
- Oncology
- CNS Disorders
- Infectious Diseases
- Immunological Disorders
- Cardiovascular Disease
- Respiratory Diseases
- Diabetes
- Ophthalmology
- Pain Management
- Other

U.S. Pharmaceutical Cro Market Size & Outlook, 2026-2033

Data Tree

Sign up - it's easy, and free!